472 related articles for article (PubMed ID: 19157480)
21. Rev and Rex proteins of human complex retroviruses function with the MMTV Rem-responsive element.
Mertz JA; Lozano MM; Dudley JP
Retrovirology; 2009 Feb; 6():10. PubMed ID: 19192308
[TBL] [Abstract][Full Text] [Related]
22. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
23. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors.
Schambach A; Wodrich H; Hildinger M; Bohne J; Kräusslich HG; Baum C
Mol Ther; 2000 Nov; 2(5):435-45. PubMed ID: 11082317
[TBL] [Abstract][Full Text] [Related]
24. Improved safety and titre of murine leukaemia virus (MLV)-based retroviral vectors.
Zhao Y; Low W; Collins MK
Gene Ther; 2000 Feb; 7(4):300-5. PubMed ID: 10694810
[TBL] [Abstract][Full Text] [Related]
25. Sequence relationships of type D retroviruses which cause simian acquired immunodeficiency syndrome.
Thayer RM; Power MD; Bryant ML; Gardner MB; Barr PJ; Luciw PA
Virology; 1987 Apr; 157(2):317-29. PubMed ID: 2435057
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoids regulate expression of the v-mycOK10 oncogene in a murine retroviral vector with chimeric MoMuLV-MMTV LTRs.
Jacquemin-Sablon H; Bogenberger J
Biochem Int; 1990; 20(4):669-79. PubMed ID: 2162166
[TBL] [Abstract][Full Text] [Related]
27. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
28. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
Brandtner EM; Kodajova P; Hlavaty J; Jandl G; Tabotta W; Salmons B; Günzburg WH; Hohenadl C
J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
[TBL] [Abstract][Full Text] [Related]
29. WPRE-mediated enhancement of gene expression is promoter and cell line specific.
Klein R; Ruttkowski B; Knapp E; Salmons B; Günzburg WH; Hohenadl C
Gene; 2006 May; 372():153-61. PubMed ID: 16488559
[TBL] [Abstract][Full Text] [Related]
30. Characterization of transient expression system for retroviral vector production.
Hotta A; Saito Y; Kyogoku K; Kawabe Y; Nishijima K; Kamihira M; Iijima S
J Biosci Bioeng; 2006 Apr; 101(4):361-8. PubMed ID: 16716946
[TBL] [Abstract][Full Text] [Related]
31. Mouse mammary tumor virus (MMTV), a retrovirus that exploits the immune system. Genetics of susceptibility to MMTV infection.
Ross SR; Dzuris JL; Golovkina TV; Clemmons WC; van den Hoogen B
Medicina (B Aires); 1997; 57 Suppl 2():34-42. PubMed ID: 9567342
[TBL] [Abstract][Full Text] [Related]
32. Abundant authentic MMTV-Env production from a recombinant provirus lacking the major LTR promoter.
Rungaldier S; Nejad Asl SB; Günzburg WH; Salmons B; Rouault F
Virology; 2005 Nov; 342(2):201-14. PubMed ID: 16140354
[TBL] [Abstract][Full Text] [Related]
33. Reciprocal cross-packaging of primate lentiviral (HIV-1 and SIV) RNAs by heterologous non-lentiviral MPMV proteins.
Al Shamsi IR; Al Dhaheri NS; Phillip PS; Mustafa F; Rizvi TA
Virus Res; 2011 Jan; 155(1):352-7. PubMed ID: 20875467
[TBL] [Abstract][Full Text] [Related]
34. A novel, mouse mammary tumor virus encoded protein with Rev-like properties.
Indik S; Günzburg WH; Salmons B; Rouault F
Virology; 2005 Jun; 337(1):1-6. PubMed ID: 15914215
[TBL] [Abstract][Full Text] [Related]
35. Analysis of ALV-based packaging cell lines for production of contaminant defective viruses.
Girod A; Cosset FL; Verdier G; Ronfort C
Virology; 1995 Jun; 209(2):671-5. PubMed ID: 7778301
[TBL] [Abstract][Full Text] [Related]
36. Sequences in the 5' leader of Mason-Pfizer monkey virus which affect viral particle production and genomic RNA packaging: development of MPMV packaging cell lines.
Guesdon FM; Greatorex J; Rhee SR; Fisher R; Hunter E; Lever AM
Virology; 2001 Sep; 288(1):81-8. PubMed ID: 11543660
[TBL] [Abstract][Full Text] [Related]
37. VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression.
Yoshida Y; Emi N; Hamada H
Biochem Biophys Res Commun; 1997 Mar; 232(2):379-82. PubMed ID: 9125185
[TBL] [Abstract][Full Text] [Related]
38. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
[TBL] [Abstract][Full Text] [Related]
39. Analysis of human lymphotropic T-cell virus type II-like particle production by recombinant baculovirus-infected insect cells.
Takahashi RH; Nagashima K; Kurata T; Takahashi H
Virology; 1999 Apr; 256(2):371-80. PubMed ID: 10191202
[TBL] [Abstract][Full Text] [Related]
40. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery.
Ghani K; Cottin S; de Campos-Lima PO; Caron MC; Caruso M
J Gene Med; 2009 Aug; 11(8):664-9. PubMed ID: 19507185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
